Skip to main content

Waters Completes NuGenesis Acquisition

NEW YORK, March 5 (GenomeWeb News) - Waters announced today that it has completed its acquisition of Westborough, Mass.-based NuGenesis Technologies.

 

The mass spectrometer and chromatography vendor announced in January that it would acquire the bioinformatics company for $43 million.

 

Waters said that in line with the acquisition, it will be revealing plans for its informatics businesses at the Pittcon conference in Chicagonext week.

 

"With the 2003 acquisition of Croen Lab Control and the more recent purchase of NuGenesis Tehcnologies, Waters now has a comprehensive range of products for scientific data management. We are now much more thanan instrument company," Waters' president, Art Caputo, commented in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.